Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal HEIR Study
NCT03584217Phase 2Unknown
- Sponsor
- University of Colorado Denver
- Start
- Oct 2018
- Primary completion
- Jun 2023
- Countries
- 1
01
Overview
Phase 2, open-label trial (3 arms), sponsored by University of Colorado Denver. Primary endpoints: Effective Renal Plasma Flow at 4 hours and Glomerular Filtration Rate at 4 hours. Status: unknown.
Beyond the preview
Go deeper on NCT03584217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03584217.